Circulating Biomarkers and Ventricular Tachyarrhythmia

Completed

Conditions studied: Cardiomyopathy, Ventricular Tachycardia, Ventricular Fibrillation

In brief

The purpose of this study is to determine whether levels of inflammatory markers in circulating blood can correlate with risk for dangerous heart rhythms. Patients with systolic heart failure, which has been shown to increase risk for dangerous heart rhythms, will be enrolled. All subjects will have an implantable cardioverter-defibrillator (ICD) in place, which allows regular evaluation of heart rhythm.

Key facts

Study ID

NCT01892462

Run by

Ochsner Health System

People needed

220

Starts

2012-06-01

Expected to finish

2016-10-01

Last updated by the study team

2017-04-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• left ventricular ejection fraction [LVEF] <=35%
• ICD implant

You may not qualify if…

• Recent myocardial infarction (12 weeks)
• Recent revascularization (12 weeks)
• Recent hospitalization for any cause (6 weeks)
• History of rheumatologic disease

Where it is running

• Ochsner Health System — New Orleans, Louisiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.